Technical Analysis for BRTX - BioRestorative Therapies, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 1.56 | 0.00% | 0.00 |
Earnings due: Nov 11
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
200 DMA Support | Bullish | 0.00% | |
Stochastic Buy Signal | Bullish | 0.00% | |
Spinning Top | Other | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
20 DMA Resistance | Bearish | 0.00% |
Alert | Time |
---|---|
200 DMA Support | about 20 hours ago |
Rose Above 10 DMA | about 20 hours ago |
Lower Bollinger Band Support | about 20 hours ago |
Possible Inside Day | about 22 hours ago |
Fell Below 200 DMA | about 22 hours ago |
Get a Trading Assistant
- Earnings date: 11/11/2024
BioRestorative Therapies, Inc. Description
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100 that has completed Phase 1 clinical trials is a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate, which is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue (BAT). In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Stem Cell Cell Therapy Cell Biology Obesity Therapeutic Products Regenerative Medicine Metabolic Disorders Adult Stem Cell Mesenchymal Stem Cell Stem Cell Therapy Non Surgical Treatment
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.6699 |
52 Week Low | 1.03 |
Average Volume | 22,053 |
200-Day Moving Average | 1.54 |
50-Day Moving Average | 1.64 |
20-Day Moving Average | 1.63 |
10-Day Moving Average | 1.59 |
Average True Range | 0.10 |
RSI (14) | 43.18 |
ADX | 11.29 |
+DI | 19.66 |
-DI | 16.02 |
Chandelier Exit (Long, 3 ATRs) | 1.49 |
Chandelier Exit (Short, 3 ATRs) | 1.79 |
Upper Bollinger Bands | 1.75 |
Lower Bollinger Band | 1.51 |
Percent B (%b) | 0.2 |
BandWidth | 14.46 |
MACD Line | -0.03 |
MACD Signal Line | -0.02 |
MACD Histogram | -0.0123 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.67 | ||||
Resistance 3 (R3) | 1.67 | 1.63 | 1.65 | ||
Resistance 2 (R2) | 1.63 | 1.60 | 1.63 | 1.65 | |
Resistance 1 (R1) | 1.59 | 1.58 | 1.61 | 1.60 | 1.64 |
Pivot Point | 1.56 | 1.56 | 1.56 | 1.56 | 1.56 |
Support 1 (S1) | 1.52 | 1.53 | 1.54 | 1.52 | 1.48 |
Support 2 (S2) | 1.48 | 1.51 | 1.48 | 1.47 | |
Support 3 (S3) | 1.45 | 1.48 | 1.47 | ||
Support 4 (S4) | 1.45 |